Endoscopic ultrasonography (EUS) is considered one of the most accurate methods for the diagnosis and staging of pancreatic tumors. EUS-guided fine-needle aspiration (FNA) allows to increase the diagnostic accuracy of EUS in this setting; however, it is technically demanding (a pathologist is also essential) and is furthermore associated with small, but not insignificant morbidity. EUS pancreatic elastography, by analyzing tissue stiffness, arises as a new and very useful tool for the differential diagnosis of solid pancreatic masses. Elastography provides specific patterns supporting the benign or malignant nature of the disease. However, there is a handicap related to the subjective interpretation of images. Second-generation elastography has been recently developed, and allows a quantitative analysis of tissue stiffness. It is based on the determination of a strain ratio (obtained after comparing the strain value of the mass to a strain value from a control area in the region under study). We present two cases reflecting the usefulness of second-generation elastography in the differential diagnosis between pancreatic adenocarcinoma and an inflammatory mass in the context of chronic pancreatitis. We found significant differences between both masses in the strain ratio values (25.46% in the pancreatic adenocarcinoma vs. 2.35% in the inflammatory mass). Second-generation elastography is a very useful tool for the differential diagnosis of solid pancreatic masses.
INTRODUCTION
Endoscopic ultrasonography (EUS) has become a basic tool for the study of pancreatic diseases, and is considered one of the most accurate methods for the diagnosis and staging of both chronic inflammatory and neoplastic pancreatic diseases (1, 2) . However, differentiation between pancreatic cancer and focal pancreatitis remains a challenge. EUS can guide fine-needle aspiration (EUS-FNA) for the collection of cytological samples from pancreatic lesions with a very high overall diagnostic accuracy (3) (4) (5) (6) (7) . EUS-FNA may be, however, technically demanding, and multiple puncturing of pancreatic lesions may be needed to obtain adequate material for cytological or microhistological evaluation. EUS-FNA of the pancreas, despite being considered very safe, is furthermore associated with a small, but not insignificant morbidity (8, 9) .
Elastography is a method for the real-time evaluation of tissue stiffness, which has been used for the analysis of superficial organ lesions such as those of the breast (10) (11) (12) (13) . Images obtained by elastography represent tissue elasticity, which may reflect histopathological differences (14) . The association of this technology with EUS has implied a significant advance in the management of pancreatic diseases, mainly in the differential diagnosis of pancreatic tumors (15) .
Second-generation endoscopic ultrasound elastography in the differential diagnosis of solid pancreatic masses. Pancreatic cancer vs. inflammatory mass in chronic pancreatitis
A new advance has been recently developed -secondgeneration elastography. This technique allows not only a qualitative elastographic analysis, but also a quantitative analysis based on the determination of a strain ratio (obtained after comparing the strain value of the mass to a strain value from a control area in the region under study). Data published on this new technique are scarce. We present two cases reflecting the usefulness of secondgeneration elastography in the differential diagnosis of solid pancreatic masses. One of these cases is a patient with pancreatic cancer, the other is a patient with an inflammatory mass in the context of chronic pancreatitis.
METHODS
EUS was performed with a linear EUS probe (EG 3830 UTK; Pentax Europe GmbH, Hamburg, Germany) attached to the EUB 900 (Hitachi Medical Systems GmbH, Wiesbaden, Germany) platform, which includes the elastography module. This module enables real-time elastographic evaluation and recording. The technology is based on the detection of small structure deformations within the B-mode imaging caused by compression, so that the strain is smaller in hard tissue than in soft tissue (13) . The degree of deformation is used as an indicator of tissue stiffness (14, 16) . Different elasticity values are marked with different colors, resulting in different tissue elasticity patterns. The system is set up to use a hue color map (red-green-blue) where hard tissue areas are shown in dark blue, moderately hard tissue areas in cyan, intermediate tissue areas in green, moderately soft tissue areas in yellow, and soft tissue areas in red (17) . EUS elastography was performed by using a two-panel image with the usual conventional grey-scale B-mode EUS image on the right side and the elastographic image on the left side. The region of interest (ROI) for the elastographic evaluation was manually selected and included the whole targeted lesion when possible, as well as surrounding tissues, which were used for control (15) . For the performance of second-generation elastography, also developed by Hitachi, two different areas (A and B) from the region of interest were selected for the quantitative elastographic analysis: area A is representative of a mass and area B refers to a soft reference area. The B/A quotient (strain ratio) is considered the result of the elastographic evaluation.
To obtain elastographic images, the probe was pressed against the wall with only the pressure needed for an optimal and stable B-mode image at 7.5 MHz. Since elastography images tend to show rapid changing colors, a stable image for at least five seconds was required for final pattern definition.
Once EUS elastography was performed and the elastographic pattern defined, a EUS-FNA procedure of the pancreatic mass was carried out in both patients with a 22-gauge needle (Echo-Tip from Wilson-cook Medical, Winston-Salem, North Carolina, USA; and Sonotip II, Mediglobe, Germany) in order to obtain a final diagnosis.
CASE REPORTS

Case 1
A 43-year-old woman with a medical history of meningitis in childhood, gestational diabetes, and gravidic cholestasis, and previously diagnosed with idiopathic chronic pancreatitis was admitted to our department for epigastric abdominal pain associated with jaundice for the last 48 hours. A CT scan was performed, which identified multiple pancreatic calcifications with an enlarged head of the pancreas (reaching 6 cm in diameter) and duodenal infiltration. There was also a slight dilation of the main pancreatic duct, as well as enlarged periaortic and mesenteric lymph nodes. The first diagnosis established was suspicion of an inflammatory mass in the context of chronic pancreatitis, but with concern regarding degeneration towards pancreatic cancer. EUS was performed, which confirmed the presence of a heteroechogenic, irregular mass at the head of the pancreas with calcifications both inside the mass and across the remaining parenchyma. The pancreatic parenchyma also presented with hyperechoic foci, hyperechoic strands and lobularity with honeycombing (characteristic of chronic pancreatitis). The main pancreatic duct was dilated with a Fig. 1 . Second-generation elastographic study (quantitative evaluation) of a mass located at the head of the pancreas that in the baseline study showed a heterogeneous green-predominant pattern with a strain ratio of 2.35, and an A value (corresponding to the mass) of 0.12%. These findings are characteristic of inflammatory masses, and allow the exclusion of malignancy.
hyperechoic wall and dilated side branches. The pancreatic mass infiltrated and dilated the common bile duct. An elastographic evaluation was performed during EUS. In the baseline study the mass had a heterogeneous green-predominant pattern with scarce yellow and red lines; in the second-generation analysis the strain ratio was 2.35, with an A value (corresponding to the mass) of 0.12%. A EUS-FNA procedure was performed, which showed the characteristic changes of an inflammatory mass in the context of chronic pancreatitis (18) . Finally, an endoscopic retrograde cholangio-pancreatography (ERCP) was performed, and a plastic stent was placed. The patient evolved satisfactorily, and after three months of follow-up she remains stable and asymptomatic.
Case 2
A 79-year-old man with a medical history of hypertensive cardiopathy with atrial fibrillation and transitionalcell bladder cancer, a smoker of 20 cigarettes a day until 70 years of age, and a previous drinker of 80 g of ethanol per day, was admitted to our department for epigastric abdominal pain associated with weight loss (8 kg over the last two months) for the last 3 weeks. A helical CT scan was performed, which identified an irregular, 3-cm lesion located at the head of the pancreas, with vascular infiltration (mainly porto-mesenteric axis, with a significant alteration on the color-doppler signal) and enlarged peripancreatic and celiac-trunk lymph nodes (hypoechoic, rounded, bigger than 1 cm, suggesting tumoral origin). The first diagnosis established was suspicion of a pancreatic tumor, probably pancreatic adenocarcinoma. A EUS procedure was performed, which confirmed the presence of a solid, irregular, poorly echogenic mass at the head of the pancreas. EUS also confirmed the vascular infiltration. The elastographic evaluation was performed during EUS. In the baseline study the mass had a heterogeneous blue-predominant pattern with scarce green areas and red lines, and a geographic appearance; in the second-generation analysis the strain ratio was 25.46, with an A value (corresponding to the mass) of 0.01%. A EUS-FNA procedure was performed, which confirmed the diagnosis of pancreatic adenocarcinoma. The patient was referred to Oncology because the tumor was considered unresectable due to vascular infiltration and the patient nonoperable because of his cardiovascular disease. After three months of follow-up the patient exhibits tumor progression (in the last control visit liver metastases were found) and under palliative treatment.
DISCUSSION
Elastography allows a real-time evaluation of tissue stiffness or hardness using conventional ultrasound equipments. Some pathological conditions, like malignant tumors, often induce changes in the mechanical properties of tissues. Elasticity is usually uniform in benign lesions; however, malignant tumors grow in a much disorganized way, and present with heterogeneous elasticity throughout the tumor (19) . In this context, the association of this technology with EUS means a significant advance in the management, for instance, of pancreatic diseases. EUS-elastography has demonstrated its usefulness in the diagnosis of chronic pancreatitis, and mainly in the differential diagnosis of pancreatic tumors (15) .
Up to now, few studies on the usefulness of EUS-elastography in the differential diagnosis of solid pancreatic tumors have been reported. However, almost all of these studies have the same problem -the handicap of being based on a subjective interpretation of the color pattern obtained during conventional elastographic evaluation. In the first study, published by Giovannini et al., elastography showed a sensitivity of 100% and a specificity of 67% to determine the malignant nature of solid pancreatic tumors. In this study, malignant lesions had mainly a blue color pattern, whereas other color patterns were considered benign. They were able to correctly identify all patients with malignant tumors; however, some benign masses were also classified as malignant. They proposed a new classification based on the predominant color and image pattern (20) . Afterwards, in a study performed by our group in 80 pancreatic solid lesions and 10 healthy controls, four different elastographic patterns could be observed. A homogeneous green elastographic pattern Fig. 2 . Second-generation elastographic study (quantitative evaluation) of a pancreatic tumor located at the head of the pancreas that in the baseline study had a heterogeneous blue-predominant pattern, and a geographic appearance, with a strain ratio of 25.46 and an A value (corresponding to the mass) of 0.01%. These findings significantly support the malignant nature of the tumor.
was only seen in all 10 normal pancreas controls. A heterogeneous green-predominant elastographic pattern was seen in 18 of the 23 inflammatory masses, and in none of the malignant tumors. A heterogeneous blue-predominant pattern with a geographic appearance was seen in 48 pancreatic adenocarcinomas and in a metastatic tumor, but also in five inflammatory masses. Finally, a homogeneous blue elastographic pattern was identified only in all 8 cases of neuroendocrine tumors. With these findings, EUS-elastography showed a sensitivity of 100%, a specificity of 78%, and an overall accuracy of 93.7% in the evaluation of solid pancreatic tumors (21) . However, Jansen et al. showed not-so-optimistic results. In a subanalysis performed in their study, including only patients with solid pancreatic masses, they described in all of them a similar pattern, mixed heterogeneous green and blue, with an irregular distribution, except in cases of endocrine tumors (with more homogeneous patterns). However, they only included one inflammatory mass in the context of chronic pancreatitis, and it was thus difficult to compare with previous studies, which included a significant, higher number of inflammatory masses (22) . Similar data are presented in a recent study including 70 patients with solid pancreatic tumors, and 10 healthy controls. Authors could only complete the elastographic evaluation in 56% of patients, mainly related to the difficulty of delimiting the region of interest in tumors greater than 35 mm, or in those far away from the transducer, as they could not include enough surrounding tissue for control purposes. They obtained a diagnostic sensitivity of 41% and a specificity of 53% with an overall accuracy of 45%, clearly worse than in previous studies (23) . However, it is important to point out that all 58 tumors included in the study were malignant, without a single benign lesion. Globally, all these studies presented an important limitation; they were all based on a subjective interpretation of a color-predominant pattern. Probably this fact is one of the clues explaining the different results obtained in previous studies. This is the reason why an objective and reproducible evaluation may avoid the bias related to subjective interpretations. At present, there is a system available allowing a quantitative evaluation of tissue stiffness by determining a strain ratio -second-generation elastography. This is a new and important advance in the differential diagnosis of solid pancreatic tumors. We present in this article our initial experience. We report two cases, an inflammatory mass in the head of the pancreas, and a pancreatic adenocarcinoma, both evaluated with this new technique. We have detected that the strain ratio in the inflammatory mass was significantly lower that the strain ratio of the pancreatic adenocarcinoma (2.35 vs. 25.46). We also found that the A value, corresponding to the mass, was significantly higher in the inflammatory mass as compared to the pancreatic adenocarcinoma (0.12 vs. 0.01%). It seems possible to differentiate both lesions, not only by the subjective interpretation of the color-patterns but also in an objective way using second-generation elastography. Another advance in this setting is worth mentioning. Saftoiu et al. (23) have recently published their results with a novel method based on a specially designed software, which allows a quantitative analysis by calculating hue histograms for each individual elastographic image. They included 22 normal pancreas controls, 11 patients with chronic pancreatitis, 32 pancreatic adenocarcinomas, and 3 neuroendocrine tumors. Using a cut-off of 175 points, they could differentiate between benign and malignant pancreatic lesions with a sensitivity, specificity, and accuracy of 91.4, 87.9 and 89.7%, respectively (24) .
We can conclude that second-generation elastography shows promising data as a useful tool for the differential diagnosis of solid pancreatic tumors (mainly to differentiate benign from malignant lesions). In our initial experience, we obtained significantly different values between a benign inflammatory mass (in the context of chronic pancreatitis) and a malignant pancreatic tumor (pancreatic adenocarcinoma). However, new prospective studies are needed to confirm the usefulness of this new technique in this setting. 
Elastografía ecoendoscópica de segunda generación en el diagnóstico diferencial de las lesiones sólidas pancreáticas. Cáncer de páncreas vs. masa inflamatoria en pancreatitis crónica
RESUMEN
La ultrasonografía endoscópica (USE) es la técnica más eficaz para el diagnóstico y estadiaje local de los tumores pancreáticos. La asociación de la punción guiada por USE ha permitido aumentar la rentabilidad diagnóstica, si bien es muy explorador dependiente (sin obviar el papel fundamental del patólogo) y no se encuentra exenta de complicaciones. En este contexto la elastografía pancreática emerge como una técnica de gran utilidad que permite evaluar la dureza de los tejidos, mostrando una elevada eficacia diagnóstica en el diagnóstico diferencial de los tumores pancreáti-cos. La elastografía muestra patrones muy específicos que apoyan la naturaleza maligna o benigna de las lesiones. Sin embargo existe el hándicap de la subjetividad de la interpretación de las imáge-nes. Recientemente se ha desarrollado la elastografía de 2ª generación que permite realizar un análisis cuantitativo de la elasticidad de los tejidos. Se basa en la determinación de un coeficiente de elasticidad. Nosotros presentamos dos casos que reflejan la utilidad de la elastografía de segunda generación en el diagnóstico diferencial de las lesiones sólidas pancreáticas, en concreto en la diferenciación entre un adenocarcinoma de páncreas y una masa inflamatoria en el contexto de una pancreatitis crónica. Se aprecia cómo existen diferencias significativas entre ambas lesiones en el coeficiente de elasticidad (25,46 en el adenocarcinoma de pán-creas vs. 2,35 en la masa inflamatoria). Probablemente la elastografía de segunda generación sea una herramienta útil en el diagnóstico diferencial de las lesiones sólidas pancreáticas.
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INTRODUCCIÓN
La ultrasonografía endoscópica (USE) se ha convertido en una herramienta fundamental en el estudio de la patología pancreática, siendo considerada como uno de los métodos de elección en el diagnóstico y estadiaje local de la patología inflamatoria y de los tumores pancreáticos (1, 2) . Sin embargo, la diferenciación entre un cáncer de páncreas y una lesión inflamatoria focal, continúa siendo un reto. La USE permite la realización de biopsias dirigidas de las lesiones pancreáticas, alcanzando con una elevada eficacia un diagnóstico cito-histológico (3-7). Sin embargo, la punción guiada por USE es compleja, y en ocasiones se precisan múltiples punciones para poder obtener una muestra adecuada para llegar al diagnóstico definitivo. Por ello, a pesar de ser considerada como muy segura, no se encuentra exenta de complicaciones (8, 9) .
La elastografía es un método que permite evaluar en tiempo real la dureza o elasticidad de los tejidos, desarrollándose inicialmente en la valoración de órganos superficiales, como la mama (10-13). Las imágenes obtenidas mediante el estudio elastográfico pueden ser consideradas como una aproximación a las características histoló-gicas de las diferentes tejidos analizados (14) . La asociación de este tecnología con la USE ha supuesto un avance significativo en el manejo de la patología pancreática, sobre todo en el diagnóstico diferencial de los tumores pancreáticos (15) .
Recientemente se ha desarrollado un importante avance, la elastografía de 2ª generación. Esta técnica permite no sólo realizar un estudio elastográfico cualitativo, sino también un análisis cuantitativo, basado en la determinación de un coeficiente de elasticidad. Apenas existen datos publicados en la literatura sobre este avance. Nosotros presentamos dos casos que reflejan la utilidad de la elastografía de segunda generación en el diagnóstico diferencial de las lesiones sólidas pancreáticas. Se trata de dos estudios elastográficos de segunda generación, uno en un paciente con un cáncer de páncreas y en otro con una masa inflamatoria en el contexto de una pancreatitis cró-nica.
MÉTODOS
Las USE fueron realizadas mediante un ecoendoscopio lineal (EG 3870 UTK; Pentad Europe GmbH, Hamburg, Germany) acoplado al equipo ecográfico EUB 900 (Hitachi Medical Systems GmbH, Wiesbaden, Germany), el cual incluye el modulo de elastografía. Este modulo permite realizar un estudio elastográfico en tiempo real. Se basa en la detección de pequeñas deformidades estructurales obtenidas en la imagen en modo B originadas por la compresión del transductor, de manera que la tensión originada es menor en el tejido duro, con respecto al blando (13) . El grado de deformidad se emplea como un indicador de la dureza del tejido (14, 16) . Los diferentes valores de elasticidad se marcan con diferentes colores, lo que se corresponde con diferentes patrones de elasticidad. El sistema está programado para emplear un mapa de colores (rojo-verde-azul), donde las zonas de tejido más duro se muestran en color azul, las de tejido de dure-ficaciones dispersas, tanto en relación con la lesión como en el resto de parénquima pancreático, que presenta un patrón lobular, con puntos y bandas hiperecogénicas (característico de pancreatitis crónica). El conducto pancreá-tico principal se encuentra dilatado, con pared hiperecogénica, patrón irregular y dilatación de colaterales. La lesión pancreática afecta la vía biliar principal, con dilatación secundaria de la misma. Durante la realización de la USE se realiza el estudio elastográfico. En el estudio basal se aprecia un patrón heterogéneo de predominio verde, y en el estudio elastográfico de segunda generación se aprecia un coeficiente de elasticidad de 2,35 y un valor de A (lesión a estudio) de 0,12%. Finalmente se realiza una punción aspiración con aguja fina de 22G, apreciándose hallazgos característicos de una masa inflamatoria en contexto de una pancreatitis crónica (18) . Finalmente se realiza una colangiopancreatografía retrógra-da endoscópica con colocación de una prótesis de polietileno. La paciente evolucionó de forma satisfactoria, encontrándose tras tres meses de seguimiento, estable y asintomática.
Caso 2
Varón de 79 años, con antecedentes personales de cardiopatía hipertensiva en fibrilación auricular y carcinoma de células transicionales de vejiga tratado mediante resección transuretral. El paciente fue fumador de unos 20 cigarrillos al día hasta los 70 años y es bebedor de unos 80 gramos de etanol al día. Ingresa en nuestro servicio por un cuadro de dolor abdominal epigástrico, sordo, de unas 3 semanas de evolución, junto con una pérdida ponderal de unos 8 kg en los últimos 2 meses. Se realizó al ingreso un TAC abdominal helicoidal con contraste, en el que se identifica una lesión irregular en unión cabezacuerpo de páncreas, de aproximadamente 3 cm de diáme-tro mayor, con afectación de estructuras vasculares (fundamentalmente el eje porto-mesentérico, con afectación significativa del flujo en estudio doppler) y con adenopatías peripancreáticas y en tronco celiaco, hipoecoicas, redondeadas, mayores de 1 cm, sugestivas de origen tumoral. Se establece el diagnóstico de sospecha de un tumor pancreático, probablemente un adenocarcinoma de pán-creas. Se realiza una USE, que confirma la presencia de una lesión sólida en la transición cabeza-cuerpo de pán-creas, de aspecto irregular, hipoecoico, con bordes mal delimitados. Se confirma la infiltración vascular descrita en el TAC abdominal. Durante la USE se realiza el estudio elastográfico. En el análisis basal muestra un patrón heterogéneo de predominio azul, con distribución geográfica. En el estudio elastográfico de segunda generación se aprecia un coeficiente de elasticidad de 25,46 y un valor de A (lesión a estudio) de 0,01%. Finalmente se realiza una punción aspiración con aguja fina de 22G, apreciándose hallazgos compatibles con adenocarcinoma de páncreas. El paciente es remitido a Oncología Médica sen y cols. muestran resultados menos optimistas. En el subanálisis que realizan sobre los pacientes con lesiones focales, describen en todos ellos un patrón similar, heterogéneo mixto verde y azul, con distribución irregular, salvo en el caso de tumores endocrinos que presentan patrones más homogéneos, sin embargo sólo incluyen un caso de lesión focal en el contexto de una pancreatitis crónica, siendo difícil comparar con los estudios previos, en los que el número de lesiones inflamatorias es significativamente mayor (22) . En esta misma línea, un estudio reciente que incluye 70 pacientes con lesiones sólidas pancreáticas y 10 controles sanos, los autores sólo pudieron completar el estudio elastográfico en el 56% de los pacientes, fundamentalmente por la dificultad de delimitar en la región de estudio lesiones mayores de 35 mm o en aquellas alejadas del transductor, al no poder incluir en la región de estudio suficiente tejido normal de control. Obtuvieron una sensibilidad diagnóstica del 41%, una especificidad del 53% y una eficacia global del 45%, cifras claramente inferiores a la de los estudios previos (23) . Sin embargo, en este estudio es criticable el hecho de las 58 lesiones sólidas incluidas en el estudio eran tumores malignos, sin incluir ninguna lesión benigna. De forma global, todos estos estudios presentan una importante limitación, el estar basados en una valoración elastográfica subjetiva, basada en la interpretación de un có-digo de colores. Probablemente este hecho es uno de los factores que pueden influir en estos resultados dispares. Por ello, la posibilidad de realizar una valoración objetiva y reproducible evitaría los sesgos de las interpretaciones subjetivas.
Actualmente se dispone de un sistema que permite la realización de una valoración cuantitativa de la elasticidad de los tejidos, mediante la determinación de un coeficiente de elasticidad, la elastografía de 2ª generación. Supone un nuevo e importante avance en diagnóstico diferencial de las lesiones sólidas pancreáticas. Nosotros presentamos en el presente artículo nuestra experiencia inicial. Se trata de dos casos, una masa inflamatoria en cabeza de páncreas y un adenocarcinoma de páncreas, evaluados mediante esta nueva tecnología. Hemos apreciado que el coeficiente de elasticidad obtenido en la lesión inflamatoria es significativamente menor que el caso del adenocarcinoma de páncreas (2,35 vs. 25,46) . Igualmente también hemos comprobado cómo el valor del área correspondiente con la lesión a estudio (A) es significativamente mayor en el caso de la lesión inflamatoria, con respecto al del caso del adenocarcinoma (0,12 vs. 0,01%). Parece que es posible diferenciar ambos tipos de lesiones, ya no con la valoración subjetiva de la elastografía de primera generación, sino también de forma objetiva mediante el estudio elastográfico de segunda generación. Es importante destacar que existen otros avances en este mismo sentido. Saftiou y cols. añaden la valoración objetiva mediante el análisis de los histogramas obtenidos del estudio elastográfico convencional. En su serie incluyeron 22 páncreas normales, 11 pacientes con pancreatitis crónica, 32 con adenocarcinomas de pán-creas y 3 tumores neuroendocrinos pancreáticos. Empleando un punto de corte de 175 puntos en el histograma, la técnica mostró una sensibilidad diagnóstica del 91,4%, una especificidad del 87,9%, con una eficacia global del 89,7% (24) .
En conclusión, la elastografía de segunda generación muestra datos alentadores como una herramienta útil en el diagnóstico diferencial de las lesiones sólidas pancreá-ticas (fundamentalmente en el diagnóstico diferencial entre benignidad y malignidad). En nuestra experiencia inicial hemos obtenido valores significativamente diferentes entre una lesión inflamatoria benigna (en el contexto de una pancreatitis crónica) y una lesión tumoral (adenocarcinoma de páncreas). Sin embargo, son necesarios nuevos estudios prospectivos que permitan confirmar la eficacia de esta técnica en este contexto.
